pharma · Phenylketonuria · Amyotrophic Lateral Sclerosis · PTCT
PTC THERAPEUTICS
PTC THERAPEUTICS, INC.
PTC THERAPEUTICS clinical programs — 12 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 500 Warren Corporate Center Drive, Warren, NJ 07059, US
- Founded
- 1998
- Employees
- 1,153
- Programs
- 52
- Drugs
- 21
- Patents
- 149
PTC THERAPEUTICS projects
12 ClinicalTrials.gov programs sponsored by PTC THERAPEUTICS.
PTC THERAPEUTICS has 12 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Ataluren
PTC THERAPEUTICS, INC.
Healthy
1 trial -
Deflazacort
PTC THERAPEUTICS, INC.
Renal Impairment
1 trial -
Deflazacort
PTC THERAPEUTICS, INC.
Healthy Volunteers
1 trial -
Deflazacort
PTC THERAPEUTICS, INC.
Hepatic Impairment
1 trial -
Deflazacort and rifampin
PTC THERAPEUTICS, INC.
Healthy Volunteers
1 trial -
PTC299
PTC THERAPEUTICS, INC.
Advanced Cancer
1 trial -
PTC299
PTC THERAPEUTICS, INC.
Leukemia, Myeloid, Acute
1 trial -
PTC299
PTC THERAPEUTICS, INC.
Metastatic Breast Cancer
1 trial -
PTC596
PTC THERAPEUTICS, INC.
Cancer
1 trial -
PTC596
PTC THERAPEUTICS, INC.
High Grade Glioma
1 trial -
Unesbulin
PTC THERAPEUTICS, INC.
Ovarian Cancer
1 trial -
VEGF inhibitor PTC299
PTC THERAPEUTICS, INC.
Brain and Central Nervous System Tumors
1 trial
Frequently asked questions
How many clinical projects does PTC THERAPEUTICS have?
12 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.